Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q374426> ?p ?o }
Showing triples 1 to 50 of
50
with 100 triples per page.
- Q374426 subject Q52319.
- Q374426 subject Q7108202.
- Q374426 subject Q8220099.
- Q374426 subject Q8543771.
- Q374426 abstract "Ladostigil (TV-3,326) is a novel neuroprotective agent being investigated for the treatment of neurodegenerative disorders like Alzheimer's disease, Lewy body disease, and Parkinson's disease. It acts as a reversible acetylcholinesterase and butyrylcholinesterase inhibitor, and an irreversible monoamine oxidase B inhibitor, and combines the mechanisms of action of older drugs like rivastigmine and rasagiline into a single molecule. In addition to its neuroprotective properties, ladostigil enhances the expression of neurotrophic factors like GDNF and BDNF, and may be capable of reversing some of the damage seen in neurodegenerative diseases via the induction of neurogenesis. Ladostigil also has antidepressant effects, and may be useful for treating comorbid depression and anxiety often seen in such diseases as well.".
- Q374426 atcPrefix "none".
- Q374426 casNumber "209349-27-4".
- Q374426 fdaUniiCode "SW3H1USR4Q".
- Q374426 iupacName "[(3R)-3-(prop-2-ynylamino)indan-5-yl]-N-propylcarbamate".
- Q374426 pubchem "208907".
- Q374426 thumbnail Ladostigil.png?width=300.
- Q374426 wikiPageWikiLink Q11081.
- Q374426 wikiPageWikiLink Q11085.
- Q374426 wikiPageWikiLink Q1331905.
- Q374426 wikiPageWikiLink Q1456827.
- Q374426 wikiPageWikiLink Q14863330.
- Q374426 wikiPageWikiLink Q14913510.
- Q374426 wikiPageWikiLink Q14916286.
- Q374426 wikiPageWikiLink Q15409379.
- Q374426 wikiPageWikiLink Q154430.
- Q374426 wikiPageWikiLink Q1755122.
- Q374426 wikiPageWikiLink Q18028862.
- Q374426 wikiPageWikiLink Q1981368.
- Q374426 wikiPageWikiLink Q3271540.
- Q374426 wikiPageWikiLink Q402633.
- Q374426 wikiPageWikiLink Q407983.
- Q374426 wikiPageWikiLink Q411887.
- Q374426 wikiPageWikiLink Q420457.
- Q374426 wikiPageWikiLink Q420685.
- Q374426 wikiPageWikiLink Q427492.
- Q374426 wikiPageWikiLink Q42844.
- Q374426 wikiPageWikiLink Q52319.
- Q374426 wikiPageWikiLink Q7108202.
- Q374426 wikiPageWikiLink Q76560.
- Q374426 wikiPageWikiLink Q8220099.
- Q374426 wikiPageWikiLink Q8386.
- Q374426 wikiPageWikiLink Q8543771.
- Q374426 atcPrefix "none".
- Q374426 casNumber "209349".
- Q374426 iupacName "[-3-indan-5-yl]-N-propylcarbamate".
- Q374426 pubchem "208907".
- Q374426 unii "SW3H1USR4Q".
- Q374426 type ChemicalSubstance.
- Q374426 type Drug.
- Q374426 type ChemicalObject.
- Q374426 type Thing.
- Q374426 type Q8386.
- Q374426 comment "Ladostigil (TV-3,326) is a novel neuroprotective agent being investigated for the treatment of neurodegenerative disorders like Alzheimer's disease, Lewy body disease, and Parkinson's disease. It acts as a reversible acetylcholinesterase and butyrylcholinesterase inhibitor, and an irreversible monoamine oxidase B inhibitor, and combines the mechanisms of action of older drugs like rivastigmine and rasagiline into a single molecule.".
- Q374426 label "Ladostigil".
- Q374426 depiction Ladostigil.png.